Antiplatelet Resistance in Patients with Atherosclerosis

Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramirez, C., Sabate, M., Jimenez-Quevedo, P., Macaya, C. (2005). Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes,54 (8), 2430–2435.10.2337/diabetes.54.8.243016046311Search in Google Scholar

Badimon, L., Padró, T., Vilahur, G. (2012). Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur. Heart J. Acute Cardiovasc. Care, 1 (1), 60–74.10.1177/2048872612441582376054624062891Search in Google Scholar

Balucani, C., Barlinn, K., Zivanovic, Z., Parnetti, L., Silvestrini, M., Alexandrov, A. V. (2010). Dual antiplatelet therapy in secondary prevention of ischemic stroke: A ghost from the past or a new frontier? Stroke Res. Treat., DOI 2010:427418.10.4061/2010/427418Search in Google Scholar

Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., et al. (2001). Cyclooxygenase inhibitors and the antiplateleteffects of aspirin. New Engl. J. Med.,345, 1809–1817.10.1056/NEJMoa00319911752357Search in Google Scholar

Feher, G., Feher, A., Pusch, G., et al. (2010). Clinical importance of aspirin and clopidogrel resistance. World J. Cardiol., 2 (7), 171–186.10.4330/wjc.v2.i7.171299891621160749Search in Google Scholar

Feher, G., Feher, A., Pusch, G., Lupkovics, G., Szapary, L., Papp, E. (2009). The genetics of antiplatelet drug resistance. Clin. Genet.,75 (1), 1–18.10.1111/j.1399-0004.2008.01105.x19067731Search in Google Scholar

Ferreira, I. A., Mocking, A. I., Feijge, M. A., et al. (2006). Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler. Thromb. Vasc. Biol.,26, 417–422.10.1161/01.ATV.0000199519.37089.a016339499Search in Google Scholar

Fiolaki, A., Katsanos, A. H., Kyritsis, A. P., Papadaki, S., Kosmidou, M., Moschonas, I. C. Giannopoulos, S. (2017). High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis. J. Neurol. Sci., 376, 112–116.10.1016/j.jns.2017.03.01028431593Search in Google Scholar

Freedman, J. E., Hylek, E. M. (2009). Clopidogrel, genetics, and drug responsiveness. New Engl. J. Med.,360 (4), 411–413.10.1056/NEJMe081051319164193Search in Google Scholar

Goodman, T., Ferro, A., Sharma, P. (2008). Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Brit. J. Clin. Pharmacol., 66 (2), 222–232.10.1111/j.1365-2125.2008.03183.x249291318429969Search in Google Scholar

Gurbel, P. A., Tantry, U. S. (2007). Clopidogrel resistance? Thrombosis Res., 120 (3), 311–321.10.1016/j.thromres.2006.08.012Search in Google Scholar

Karepov, V., Tolpina, G., Kuliczkowski, W., Serebruany, V. (2008). Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke. Cerebrovas. Dis., 26 (3), 272–276.10.1159/00014745518648200Search in Google Scholar

Krasopoulos, G., Brister, S. J., Beattie,W. S., Buchanan, M. R. (2008). Aspirin “resistance” and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ,336, 195–198.10.1136/bmj.39430.529549.BESearch in Google Scholar

Mansour, K., Taher, A. T., Musallam, K. M., Alam, S. (2009). Aspirin resistance. Adv. Hematol. 10.1155/2009/937352. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19960045 (accessed 15.05.2019).10.1155/2009/937352Search in Google Scholar

Motovská, Z., Varvarovský, I., Ostádal, P. (2017). ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa, 59 (6), e592–e612.10.1016/j.crvasa.2017.10.007Search in Google Scholar

Poulsen, T. S., Jorgensen, B., Korsholm, L., et al. (2017). Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction. Thromb. Res.,119, 555–562.10.1016/j.thromres.2006.04.005Search in Google Scholar

Jones, R., Arps, K., Davis, D. M., Blumenthal, R., Martin, S. S. (2018). Clinician Guide to the ABCs of Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Available from: https://www.acc.org/latest-in-cardiology/articles/2018/03/30/18/34/clinician-guide-to-the-abcs (accessed 15.05.2019).Search in Google Scholar

Simon, T., Verstuyft, C., Mary-Krause, M., et al. (2009). Genetic determinants of response to clopidogrel and cardiovascular events. New Engl. J. Med.,360 (4), 363–375.10.1056/NEJMoa0808227Search in Google Scholar

Snoep, J. D., Hovens, M. M., Eikenboom, J. C., van der Bom, J. G., Jukema, J. W., Huisman, M. V. (2007). Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Amer. Heart J., 154, 221–231.10.1016/j.ahj.2007.04.014Search in Google Scholar

Wang, C. B., Hu, D. Y., Shi, X. B., et al. (2006). Aspirin resistance in patients taking small dose of aspirin. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 18, 219–223.Search in Google Scholar

Wang, T. H., Bhatt, D. L., Topol, E. J. (2005). Aspirin and clopidogrel resistance: An emerging clinical entity. Eur. Heart J., 27 (6), 647–654.10.1093/eurheartj/ehi684Search in Google Scholar

Weber, A. A., Zimmerman, K. C., Meyer-Kirchrath, J, Schor, K. (1999). Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet,353, 900.10.1016/S0140-6736(99)00498-5Search in Google Scholar

Wong, K. S. L., Wang, Y., Leng, X., Mao, C., Tang, J., Bath, P. M. W., Wang, Y. (2013). Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack. Circulation, 128 (15), 1656–1666.10.1161/CIRCULATIONAHA.113.00318724030500Search in Google Scholar

Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schror, K., Hohlfeld, T. (2003). Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation,108, 542–547.10.1161/01.CIR.0000081770.51929.5A12874188Search in Google Scholar